Article Review: Impact of Unjustified Medicine Price Hikes - Analysis
VerifiedAdded on 2020/05/08
|4
|780
|85
Report
AI Summary
This article review examines the significant issue of unjustified price increases for life-saving medicines, focusing on the case of Daraprim. The review discusses the actions of Turing Pharmaceuticals, which dramatically raised the price of the drug, and the resulting public outcry. It explores the social and business implications, highlighting ethical concerns and the impact on accessibility for the middle class. The analysis includes a discussion of SWOT and PEST tools used to evaluate the pharmaceutical company's actions and the broader context of medicine pricing. The review emphasizes the need for solutions to address the rising costs of essential medications and the importance of fair pricing to ensure access for all socio-economic backgrounds. References to relevant research are also provided.
1 out of 4